ライフサイエンスコーパス: suicidal behavior

1 ng in depressed individuals with and without suicidal behavior.

2 t blunted interoception may be implicated in suicidal behavior.

3 events is key to understanding the timing of suicidal behavior.

4 d endophenotype of both bipolar disorder and suicidal behavior.

5 nto single composite measures of exposure to suicidal behavior.

6 been associated with depressive symptoms and suicidal behavior.

7 sts after accounting for rates of underlying suicidal behavior.

8 ggest a protective effect of lithium against suicidal behavior.

9 st including offending, psychopathology, and suicidal behavior.

10 4 to 6 years of age predicted depression and suicidal behavior.

11 ials to reduce risk for later depression and suicidal behavior.

12 ild abuse, bullying, internet use, and youth suicidal behavior.

13 and risk factors for adolescent suicide and suicidal behavior.

14 s of sex in influencing risk for suicide and suicidal behavior.

15 the hypothalamic-pituitary-adrenal axis with suicidal behavior.

16 parents with a history of mood disorder and suicidal behavior.

17 elineate patterns and correlates of nonfatal suicidal behavior.

18 sful life events, developmental history, and suicidal behavior.

19 dent predictive role of nightmares in future suicidal behavior.

20 eptor gene is associated with depression and suicidal behavior.

21 ociated with major depression and, possibly, suicidal behavior.

22 ip between sleep, psychopathology, and youth suicidal behavior.

23 e treatment, may also be used in research on suicidal behavior.

24 or therapeutic intervention in patients with suicidal behavior.

25 lations across episodes were for anxiety and suicidal behavior.

26 protect such at-risk individuals from future suicidal behavior.

27 as in the design of intervention studies for suicidal behavior.

28 cide attempters with siblings discordant for suicidal behavior.

29 gest that CREB may play an important role in suicidal behavior.

30 subjects), we examined the status of CREB in suicidal behavior.

31 treatment conditions, and the likelihood of suicidal behavior.

32 nt role in the pathophysiological aspects of suicidal behavior.

33 ot being loved by their parents and parental suicidal behavior.

34 omorbid PTSD and major depressive episode on suicidal behavior.

35 on should lead to a significant reduction in suicidal behavior.

36 pressive episode also increases the risk for suicidal behavior.

37 ficant proportion of the variance for future suicidal behavior.

38 ported by associations with disabilities and suicidal behavior.

39 ay play a pivotal role in the development of suicidal behavior.

40 clinical relevance in the pathophysiology of suicidal behavior.

41 levels of trait impulsivity, aggression, and suicidal behavior.

42 ty appears to be an important determinant of suicidal behavior.

43 ons and the pathophysiological mechanisms of suicidal behavior.

44 sions have been considered a risk factor for suicidal behavior.

45 development of impulsivity, aggression, and suicidal behavior.

46 mutilate themselves are at greater risk for suicidal behavior.

47 n the types of substances used in predicting suicidal behavior.

48 erent DSM-III-R axis I diagnoses and no past suicidal behavior.

49 n are related in the absence of a history of suicidal behavior.

50 ables correlated with prospectively observed suicidal behavior.

51 nce links infections to mental disorders and suicidal behavior.

52 and dependence in predicting first onset of suicidal behavior.

53 and semistructured interview assessments of suicidal behavior.

54 ors to the familial coaggregation of OCD and suicidal behavior.

55 ely support disrupted vmPFC value signals in suicidal behavior.

56 can be useful for predicting future risk of suicidal behavior.

57 e on average) prediction of patients' future suicidal behavior.

58 ch has been linked to the pathophysiology of suicidal behavior.

59 be used to predict patients' future risk of suicidal behavior.

60 e conditions should be closely monitored for suicidal behavior.

61 ing and after the ED visit decreased post-ED suicidal behavior.

62 ED-initiated intervention reduces subsequent suicidal behavior.

63 ic disorders, including problem gambling and suicidal behavior.

64 alternative to lithium, are inconsistent for suicidal behavior.

65 es are critical in developing depression and suicidal behavior.

66 at collectively showed the complex nature of suicidal behavior.

67 1.2% (N=20,246) met the case definition for suicidal behavior.

68 disrupting cellular pathways associated with suicidal behavior.

69 ding schizophrenia and psychotic illness and suicidal behavior.

70 sion models were used to study predictors of suicidal behavior.

71 so suggests that inflammation is involved in suicidal behavior.

72 ish national registry data for prediction of suicidal behavior.

73 role in the pathophysiological mechanisms of suicidal behavior.

74 the development of psychiatric disorders and suicidal behavior.

75 in signaling in suicide and higher-lethality suicidal behavior.

76 al approaches to comorbidity in the study of suicidal behavior.

77 g may attenuate the familial transmission of suicidal behavior.

78 en associated with psychiatric disorders and suicidal behavior.

79 ay provide targets for reducing the risks of suicidal behaviors.

80 inking and illegal drug use, depression, and suicidal behaviors.

81 dence) disorders in statistically predicting suicidal behaviors.

82 orderline personality disorder criterion and suicidal behaviors.

83 nce, and impulsivity significantly predicted suicidal behaviors.

84 pears to be a critical element in predicting suicidal behaviors.

85 g self-injury) most strongly associated with suicidal behaviors.

86 ersons without misuse have a reduced risk of suicidal behaviors.

87 l illness onset, treatment non-response, and suicidal behaviors.

88 ch are strongly associated with self-harm or suicidal behaviors.

89 y estimation of these outcomes predispose to suicidal behavior?

90 Analogous to findings with suicidal behavior, a low concentration of CSF 5-HIAA is

91 stress disorder (PTSD) increases the risk of suicidal behavior; a major depressive episode also incre

92 linked to worse disease course and increased suicidal behavior across disorders.

93 tte smoking and the presence and severity of suicidal behavior across major psychiatric disorders may

94 ted hazard ratio=1.04, 95% CI=0.96, 1.12) or suicidal behavior (adjusted hazard ratio=0.85, 95% CI=0.

95 rders, to help identify patients at risk for suicidal behavior after major depression.

96 The risk of suicidal behavior after starting antidepressant treatmen

97 le adolescence were associated with risk for suicidal behavior after the covariates were controlled.

98 period, blind raters assessed the domains of suicidal behavior, aggression, impulsivity, anxiety, dep

99 a major risk factor for major depression and suicidal behavior along with other psychiatric illnesses

100 tudy evaluated 1-month and lifetime rates of suicidal behavior among 1,048 consecutively admitted psy

101 oportions of lipid profile predicted risk of suicidal behavior among depressed patients over the 2-ye

102 studies have indicated an increased risk of suicidal behavior among individuals with attention-defic

103 Suicidal behavior among individuals with externalizing s

104 The RR for suicidal behavior among patients first prescribed an ant

105 re was a nonsignificant reduction in risk of suicidal behavior among patients treated with fluoxetine

106 hether subtypes of DSM-IV depression predict suicidal behavior among patients with substance dependen

107 The relationship of life events to suicidal behavior among those with BPD was more complex.

108 al behavior therapy (DBT) is a treatment for suicidal behavior and borderline personality disorder wi

109 implicate abnormal serotonergic function in suicidal behavior and completed suicide, including low s

110 No associations with suicidal behavior and CSF 5-HIAA were found.

111 valuate the link between antidepressants and suicidal behavior and ideation (suicidality) in youth, a

112 Main outcomes were suicidal behavior and ideation.

113 hypothalamic-pituitary-adrenal (HPA) axis to suicidal behavior and its risk factors, such as depressi

114 Glucocorticoids increase the risk of suicidal behavior and neuropsychiatric disorders.

115 rature on the relationship between sleep and suicidal behavior and proposes directions for future res

116 authors' goals were to examine predictors of suicidal behavior and provide guidelines for assessing s

117 Probands from sibling pairs concordant for suicidal behavior and their offspring reported greater l

118 on the basis of an association with previous suicidal behavior and were tested by using Cox proportio

119 ndent of depressed mood, for the most severe suicidal behaviors and may warrant inclusion in suicide

120 e associations between opioid use/misuse and suicidal behaviors and propensity score-weighted logisti

121 The incidence and the risk of suicidal behaviors and severe neuropsychiatric disorders

122 startle reactivity, impulsivity (linked with suicidal behavior), and cognitive performance in non-smo

123 cit/hyperactivity disorder and probands with suicidal behavior, and after excluding probands and rela

124 variety of conditions including depression, suicidal behavior, and aggression.

125 hiatric hospital contacts due to depression, suicidal behavior, and all-cause mortality.

126 sive episode (N=156) were assessed for PTSD, suicidal behavior, and clinical risk factors for suicida

127 he uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnosti

128 eople because of potential increased risk of suicidal behavior, and in October 2004, the FDA issued a

129 s of transmission as well as age at onset of suicidal behavior, and its effect may be mediated by the

130 Smoking behavior, lifetime suicidal behavior, and psychopathology were assessed.

131 Although the link between insomnia and suicidal behavior appears to be mediated by depression,

132 zophrenia, the biomarkers also validated for suicidal behavior are enriched for genes involved in neu

133 Suicidal behaviors are common among US adolescents, with

134 al logistic regression models were fit, with suicidal behavior as the response variable and MDE and l

135 nt information was gathered at baseline, and suicidal behavior, aspects of alcohol dependence, and dr

136 ) months and greater lethality of subsequent suicidal behavior (b = 0.08; t = 2.89; P = .01).

137 ve potential of a stress-diathesis model for suicidal behavior based on correlates of past suicidal a

138 re no significant differences in severity of suicidal behavior between those with and without a child

139 l parents died from or were hospitalized for suicidal behavior (BPSB) relative to adoptees whose biol

140 s (>55%), treatment starts prior to onset of suicidal behaviors but fails to prevent these behaviors

141 Affective dimensions did not predict suicidal behavior, but intense feelings of love, particu

142 ing to most indices of impairment, including suicidal behavior, but pure individuals were significant

143 ctivity disorder (ADHD) is a risk factor for suicidal behavior, but the effect of ADHD medication on

144 associated with increased odds of subsequent suicidal behavior, but these exposures do not incur unif

145 id misuse is associated with greater odds of suicidal behaviors, but opioid use without misuse is not

146 shown associations between opioid misuse and suicidal behaviors, but the relationship between medical

147 ent the familial transmission of early-onset suicidal behavior by targeting these domains could reduc

148 Predicting risk of future suicidal behaviors by essential fatty acid status merits

149 and had high sensitivity and specificity for suicidal behavior classifications compared with another

150 In addition to obtaining a history of suicidal behavior, clinicians may find it useful to asse

151 It is yet unknown whether OCD and suicidal behaviors coaggregate in families and, if so, w

152 ly, these observations indicate that OCD and suicidal behaviors coaggregate in families largely due t

153 f suicide attempt greater protection against suicidal behavior compared to valproate.

154 ior exposure to suicide, suicide attempt, or suicidal behavior (composite measure-suicide or suicide

155 By contrast, exposure to suicidal behavior (composite) was associated with increa

156 19, from 13 independent studies; exposure to suicidal behavior (composite): k = 10, from 5 independen

157 Self-harm and suicidal behaviors correlated with poorer performance of

158 developed fifth edition of the DSM, NSSI and suicidal behavior disorder are for the first time introd

159 ted higher suicidal ideation and more lethal suicidal behavior during a 2-year period.

160 Subjects had a 0.06 probability of suicidal behavior during follow-up.

161 modify hopelessness and may protect against suicidal behavior during periods of risk, such as major

162 Importance: Biomarkers that predict suicidal behavior, especially highly lethal behavior, ar

163 about the specific preconditions of serious suicidal behavior, explaining the daunting array of suic

164 lp better identify subjects at high risk for suicidal behavior for targeted prevention and interventi

165 ocial impairment, psychiatric disorders, and suicidal behavior has been conducted.

166 A link between cigarette smoking and suicidal behavior has been reported in clinical and epid

167 Suicidal behavior has increased since the onset of the g

168 The vast majority of youth with suicidal behaviors have preexisting mental disorders.

169 s have estimated substantial heritability of suicidal behavior; however, collecting the sample sizes

170 isits were used to predict future documented suicidal behavior (i.e., suicide attempt or death).

171 ment of its immediate precursors, adolescent suicidal behaviors (ie, suicide ideation, plans, and att

172 f suicide attempts, and perceptions of their suicidal behavior in 30 suicide attempters with cluster

173 relative risks for newly diagnosed nonfatal suicidal behavior in 555 cases and 2062 controls were 0.

174 We aimed to quantify the risk of suicidal behavior in a large nationwide cohort of patien

175 d traits underlying both childhood abuse and suicidal behavior in adulthood disorders.

176 red diagnostic assessments of depression and suicidal behavior in assessment years 6 through 14, span

177 zed, controlled trial of pharmacotherapy for suicidal behavior in bipolar disorder.

178 he authors conducted a longitudinal study of suicidal behavior in borderline personality disorder pat

179 toms, externalizing symptoms were related to suicidal behavior in both men and women, although comorb

180 to identify clinical predictors of new-onset suicidal behavior in children of parents with a history

181 ric, and physical risk factors contribute to suicidal behavior in cocaine-dependent patients.

182 eligious affiliation is associated with less suicidal behavior in depressed inpatients.

183 Familial transmission of suicidal behavior in families with mood disorders almost

184 e helpful in the prevention and treatment of suicidal behavior in families with mood disorders.

185 Family studies have shown an aggregation of suicidal behavior in families.

186 linical environment can significantly reduce suicidal behavior in high-risk patients with bipolar I d

187 these domains could reduce the morbidity of suicidal behavior in high-risk youths.

188 opment and linked to clinical depression and suicidal behavior in humans.

189 ions are essential for reducing the risk for suicidal behavior in individuals with schizophrenia.

190 information on 15 psychiatric disorders and suicidal behavior in informants and their first-degree r

191 Research on the pathophysiology of suicidal behavior in major depressive disorder should em

192 otonin transporter binding as a predictor of suicidal behavior in MDD and determine the cause of low

193 mpaired decision making to increase risk for suicidal behavior in MDD.

194 ational, 2-year study comparing the risk for suicidal behavior in patients treated with clozapine vs

195 ng the underlying mechanisms for the risk of suicidal behavior in patients with attention-deficit/hyp

196 and serotonergic dysfunction independent of suicidal behavior in patients with axis I disorders who

197 We compared suicidal behavior in patients with borderline personalit

198 ggression independently increase the risk of suicidal behavior in patients with borderline personalit

199 In efforts to predict and prevent suicidal behavior in patients with major depressive diso

200 Risk factors for suicidal behavior in patients with psychosis appear to v

201 rare cases may lead to suicidal ideation or suicidal behavior in persons who were not known to be su

202 es, yet little is known about the drivers of suicidal behavior in poor populations.

203 r mechanism responsible for the high rate of suicidal behavior in SCZ remains poorly understood.

204 ese studies focused on the susceptibility of suicidal behavior in SCZ.

205 Panic disorder is not associated with suicidal behavior in the absence of other risk factors.

206 , 1.0; p = 0.05) and exposure to accounts of suicidal behavior in the media (adjusted OR = 0.2; 95% C

207 Exposure to accounts of suicidal behavior in the media and, to a lesser extent,

208 Predictors of suicidal behavior in the TD/CTD cohort were studied usin

209 that clozapine therapy significantly reduces suicidal behavior in these patients.

210 risk and protective factors associated with suicidal behavior in this group.

211 stance use disorder signal imminent risk for suicidal behavior in this population.

212 ficantly predict elevated odds of subsequent suicidal behaviors in bivariate models.

213 ession, mania, delirium, panic disorder, and suicidal behaviors in patients treated with glucocortico

214 found that lithium is effective at reducing suicidal behaviors in patients with mood disorders.

215 rom the prioritization step for relevance to suicidal behavior, in a demographically matched cohort o

216 volving evidence that lithium use may reduce suicidal behavior, in addition to concerns that the use

217 th mood disorders, precursors of early-onset suicidal behavior include mood disorder and impulsive ag

218 ood, hopelessness, impulsive aggression, and suicidal behavior, including lifetime number of attempts

219 an arterial input function; the severity of suicidal behaviors, including lethality and intent of su

220 oth manic and depressive symptoms as well as suicidal behavior increased monotonically from subthresh

221 Recurrent suicidal behavior is a defining characteristic of border

222 Here we tested the hypothesis that suicidal behavior is associated with heightened aversion

223 Suicidal behavior is associated with impaired decision m

224 Serious suicidal behavior is associated with impaired reward lea

225 Suicidal behavior is complex and manifests because of a

226 The ability to identify risk factors for suicidal behavior is critical to selected and indicated

227 on, twin, and family studies have shown that suicidal behavior is familial, the risk factors for fami

228 Although suicidal behavior is frequent among cocaine-dependent pa

229 hether the risk for familial transmission of suicidal behavior is greater with increased family loadi

230 Suicidal behavior is highly prevalent in borderline pers

231 The risk of suicidal behavior is increased in the first month after

232 It has been observed that suicidal behavior is influenced by sunshine and follows

233 attempts, and 2) whether the transmission of suicidal behavior is mediated by impulsive aggression.

234 usal mechanisms underlying youth suicide and suicidal behavior is needed to inform early identificati

235 Suicidal behavior is often conceptualized as a response

236 The prevention of suicidal behavior is one of the most important tasks for

237 urrent smoking is associated with subsequent suicidal behavior is unclear.

238 ist in clinical risk factors associated with suicidal behavior is unknown.

239 , a treatable risk factor, strongly predicts suicidal behaviors is cause for hope.

240 relationship between medical opioid use and suicidal behaviors is not known.

241 In identifying suicidal behavior, it is important to consider the possi

242 ollowed up for 2 years with documentation of suicidal behavior, its lethality, and suicidal ideation

243 ip rates, independent of underlying rates of suicidal behavior, largely determine variations in suici

244 ctions from these findings to depression and suicidal behavior later in life.

245 y, psychosocial impairment, quality of life, suicidal behavior, lifetime comorbid diagnoses, impulse

246 d Bonferroni correction after validation for suicidal behavior map to biological pathways involved in

247 Exposure to suicidal behavior may be associated with increased risk

248 that may exist between cigarette smoking and suicidal behavior may be associated with lower serotonin

249 gical, and personality disorders, as well as suicidal behavior, memory loss, and urinary syndromes; t

250 incidence rate ratio, 2.0; 95% CI, 1.9-2.2), suicidal behaviors, mortality, and municipal support.

251 as observed in individuals with a history of suicidal behavior (MRR = 1.28, 95% CI = 1.07-1.54) and i

252 robands whose siblings also never engaged in suicidal behavior (N=73).

253 MDE increased the risk for suicidal behavior (odds ratio (OR)=4.83, P0.0001).

254 Both exposure to the suicidal behavior of a friend or acquaintance (adjusted

255 bles, the authors found that exposure to the suicidal behavior of a parent (adjusted OR = 1.5; 95% CI

256 dia and, to a lesser extent, exposure to the suicidal behavior of friends or acquaintances may be pro

257 lethal suicide attempts and exposure to the suicidal behavior of parents, relatives, friends, or acq

258 tion, and abuse affect the mental health and suicidal behavior of trafficked children.

259 90 days before their index date (the date of suicidal behavior or ideation for cases and the same dat

260 event scores were unrelated to the timing of suicidal behavior (OR=1.06 per 100 point increase, P=0.3

261 Although most patients achieve remission of suicidal behavior over time, as many as 10% die by suici

262 Sexual abuse is a significant antecedent of suicidal behavior, particularly among women.

263 ermining whether clinical correlates of past suicidal behavior predict suicidal acts during a 2-year

264 HIAA) have been consistently associated with suicidal behavior, presenting a potential confound in th

265 icide victims to have expressed some form of suicidal behavior prior to the event (odds ratio [OR], 6

266 ears to be related to the pathophysiology of suicidal behavior rather than of major depressive disord

267 Recurrent MDE was a robust precipitant for suicidal behavior, regardless of BPD comorbidity.

268 de, the molecular mechanisms associated with suicidal behavior remain unclear.

269 Accurately predicting suicidal behavior remains challenging.

270 havior, but the effect of ADHD medication on suicidal behavior remains unclear.

271 As rates of suicidal behavior rise with the continuing global recess

272 Suicidal behavior (SB) can be impulsive or methodical; v

273 uropsychiatric disorders such as depression, suicidal behavior, schizophrenia, and Alzheimer's diseas

274 Suicidal behavior should be monitored in these patients,

275 cide attempters with siblings concordant for suicidal behavior showed a higher risk of suicide attemp

276 elation between specific antidepressants and suicidal behavior since its relation to suicidal behavio

277 probands and had an earlier age at onset of suicidal behavior than offspring of suicide attempters w

278 ar disorder is associated with high risk for suicidal behavior that often develops in adolescence and

279 Next, we validated for suicidal behavior the top-ranked biomarkers for SI, in a

280 To examine the role of this enzyme in suicidal behavior, the authors examined the catalytic an

281 antidepressant prescription to the onset of suicidal behavior, the relative risks for newly diagnose

282 ether specific delusion types are related to suicidal behaviors, the authors compared the clinical ch

283 ssive disorder did not significantly predict suicidal behaviors, the reactivity associated with affec

284 cide were female and had a family history of suicidal behavior; they reported significantly more chil

285 redictors of the emergence of depressive and suicidal behaviors throughout life.

286 Suicidal behavior was assessed at each visit.

287 ICD-9-based case definition for suicidal behavior was derived by expert clinician consen

288 Risk of suicidal behavior was estimated using conditional logist

289 and suicidal behavior since its relation to suicidal behavior was not materially different among use

290 Suicidal behavior was significantly less in patients tre

291 Risk for suicidal behaviors was increased in young adults (aged 1

292 phic, clinical, and diagnostic correlates of suicidal behavior were examined.

293 Rates of suicidal behavior were high across a broad spectrum of p

294 Suicidal behavior, which has been associated with high Q

295 rietal connectivity in impulsive people with suicidal behavior, which may underlie disrupted choice p

296 ng enable researchers to conduct research on suicidal behavior while maximizing adherence to the ethi

297 of substance misuse increase risk for future suicidal behavior, while depressive symptoms, childhood

298 ril 2000 to April 2001) regarding adolescent suicidal behavior, with particular focus on risk factors

299 am and downstream factors in the etiology of suicidal behavior, within the contextual framework of in

300 nth intervals characterized by MDE (yes/no), suicidal behavior (yes/no) and life event scores.